Radial Extracorporeal Shock Wave Therapy Versus High Power Pain Threshold Ultrasound Therapy in Supraspinatus Tendinitis (RESWTHPPTU)
Supraspinatus Tendinitis
About this trial
This is an interventional treatment trial for Supraspinatus Tendinitis focused on measuring extracorporeal shock wave, high power pain threshold ultrasound
Eligibility Criteria
Inclusion Criteria:
- Patients' age ranges from 30 to 50 years old.
- Patients are males and females.
- BMI of all subjects were <30 Kg/m2.
- Patients will be diagnosed as supraspinatus tendinitis.
- All patients are medically stable.
- All patients should be conscious and ambulant.
- Patients don't have any nervous system problems
- Patients don't have shoulder disorder other than tendenities
- Patients that didn't undergo any surgery in shoulder joint
Exclusion Criteria:
• Patients who received intra articular injection from duration less than 3 months.
- Patients with supraspinatus tendonitis secondary to trauma.
- Patients with metal implants.
- Patient who had malignancy in the affected area.
- Patient with acute infection in the treated area.
- Diabetic patients
- Bone infection
- Shoulder instability
- Epilepsy
- Coagulation diseases
- Rheumatological diseases (rheumatoid arthritis and gouty arthritis)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
group A "Control group"
group B"Extracorporeal shock wave group":
Group C"High power pain threshold ultrasound group":
Twenty two patients will receive conventional treatment hot pack and exercise (control group). .
Twenty two patients will receive Radial Extra corporeal Shock Wave Therapy plus conventional treatment hot pack and exercise.
Twenty two patients will receive High-Power Pain Threshold Ultrasound therapy plus conventional treatment hot pack and exercise